SCN4A-T704M突变相关正常血钾性周期性麻痹的临床与遗传学特征:中国两家系报道及表型异质性机制探讨OA
Clinical and genetic features of SCN4A-T704M mutation-related normokalemic periodic paralysis:A report of two Chinese families and mechanism of phenotypic heterogeneity
目的 分析中国人群中SCN4A-T704M突变相关正常血钾性周期性麻痹(normoKPP)的临床特征、遗传学基础及表型异质性机制,阐明其作为独立疾病亚型的依据.方法 纳入2个中国normoKPP家系(13例患者),收集临床数据包括:病史、检验结果、电生理、肌肉病理等,通过Sanger测序筛查SCN4A基因突变,通过家系共分离分析和美国医学遗传学与基因组学学会(ACMG)致病性评级验证突变致病性,结合文献回顾对比基因型-表型关联.对比表型异质性及种族差异.结果 所有患者均携带SCN4A基因c.2111C>T(p.T704M)(SCN4A-T704M)杂合突变,符合常染色体显性遗传;其核心表型包括幼年起病(平均年龄1.5~10岁)、发作性近端肌无力(由寒冷、饥饿、剧烈运动等诱发)、发作期血钾正常(3.5~5.5 mmol/L),部分伴腓肠肌肥大及持续性肌无力.电生理及肌肉病理学提示肌源性损害,家系内表型异质性显著{家系2年均发作次数显著高于家系1[家系1(9.5±9.2)次/年 vs 家系2(16.4±11.4)次/年]}.功能学推测突变通过钠通道慢失活缺陷引发静息漏电流,导致低阈值肌膜兴奋性异常.结论 在中国家系中SCN4A-T704M突变是normoKPP的关键致病因素,其临床症状兼具发作性与慢性肌病特征,其血钾正常、缺乏肌强直放电支持其独立疾病亚型属性.表型异质性可能与遗传修饰和环境因素交互作用相关,钠通道功能障碍导致的钙超载可能是肌纤维损伤的关键机制.研究为normoKPP的精准诊疗提供了新证据.
Objective To investigate the clinical features,genetic basis,and phenotypic heterogeneity mechanism of nor-mokalemic periodic paralysis(normoKPP)associated with SCN4A-T704M mutation in the Chinese population,and to clarify its basis as an independent disease subtype.Methods Two Chinese families(13 patients)with normoKPP were included,and re-lated clinical data were collected,including medical history,test results,electrophysiology,and muscle pathology.Sanger se-quencing was used to identify SCN4A gene mutations,and a family co-segregation analysis and ACMG pathogenicity rating were used to validate the pathogenicity of the mutations.A literature review was performed to compare genotype-phenotype associations,and phenotypic heterogeneity and racial differences were also compared.Results All patients carried the heterozygous mutation of c.2111C>T(p.T704M)in the SCN4A gene(SCN4A-T704M),which was in line with autosomal dominant inheritance,and the core phenotypes included disease onset in childhood(with a mean age of 1.5-10 years),paroxysmal proximal muscle weak-ness(induced by cold/hunger/strenuous exercise),and normal blood potassium during the ictal period(3.5-5.5 mmol/L),as well as gastrocnemius hypertrophy and persistent muscle weakness in some patients.Electrophysiology and muscle pathology sug-gested myogenic damage,with significant phenotypic heterogeneity within the family,and family 2 had a significantly higher mean annual number of attacks than family 1[(16.4±11.4)times/year vs(9.5±9.2)times/year].Functional speculation showed that the mutation triggered resting leakage current through defective slow inactivation of the sodium channel,resulting in an abnormally low threshold for muscle membrane excitability.Conclusion SCN4A-T704M mutation is a key pathogenic factor for normoKPP in Chinese families,and its clinical symptoms have the features of both episodic and chronic myopathy.Normal blood potassium and a lack of myotonic discharges support its attribute as an independent disease subtype.Phenotypic heterogeneity may be associated with the interaction between genetic modification and envi-ronmental factors,and calcium overload caused by so-dium channel dysfunction may be a key mechanism of muscle fiber injury.This study provides new evidence for the precise diagnosis and treatment of normoKPP.
熊倩倩;丁卫江;李学明
江西省丰城市人民医院神经内科,江西 丰城 331100南昌大学第二附属医院神经内科,江西 南昌 330000南昌大学第二附属医院全科医学科,江西 南昌 330000
医药卫生
正常血钾性周期性麻痹SCN4A-T704M突变表型异质性钠通道病
Normokalemic periodic paraly-sisSCN4A-T704M mutationPhenotypic hetero-geneitySodium channel disease
《中风与神经疾病杂志》 2026 (1)
70-75,6
江西省卫生健康委科技计划(SKJP1220240500)
评论